Skip to content

Insmed INSM PARI milestones — Intangible Amortization

Similar metrics at other companies

John Wiley & Sons, Inc. logo
WLYBIntangible Amortization
$13.25M+2.7%
CorMedix logo
CRMDAmortization Of Intangibles
$10.3M+19,708%
Sotera Health logo
SHCIntangible Amortization
$3.03M-80.2%
Traeger logo
COOKAmortization Of Intangible Assets, Including Cost
$10.5M-1.1%
Hayward Holdings logo
HAYWIntangible Amortization
$6.37M-6.9%
Acacia Research logo
ACTGIntellectual property operations — Intangible Amortization
$3.8M-15.6%

Other financials

Income statement

See full
Revenue$306.0M+230%
Gross profit$258.5M+261%
Operating income-$153.3M+38.2%
Net income-$163.6M+36.3%
EPS (diluted)-$0.76+46.5%

Balance sheet

See full
Cash & equivalents$582.2M+44.4%
Total debt$580.3M-49.2%
Total equity$704.9M+611%
Total assets$2.1B+15.2%

Cash flow

See full
Operating cash flow-$222.7M+15.0%
CapEx$3.5M-65.4%
Free cash flow-$226.2M+16.9%

Valuation

See full
Market cap$23.18B+19.9%
Enterprise value$23.17B+24.5%
P/S28.3×-20.3×

Profitability

See full
Gross margin81.8%+5.3pp
Operating margin-140.6%-43.9pp
Net margin-144.4%-45.3pp
FCF margin-112.5%-35.3pp

Returns & leverage

See full
Return on equity-294.5%
Debt / equity0.8×-10.7×
Current ratio4.5×-1.4×

Where this comes from

Reported directly by Insmed in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.

The official record: Insmed’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Insmed's pari milestones — intangible amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Insmed's PARI milestones — intangible amortization?
Insmed (INSM) reported PARI milestones — intangible amortization of $51K in Q1 2026.
What does PARI milestones — intangible amortization mean?
This represents the periodic expense recognized to allocate the cost of PARI-related intangible assets over their estimated useful lives. It reflects the systematic consumption of the economic value of acquired intellectual property or milestone rights. Investors use this to understand the non-cash impact of past acquisitions on current profitability.